Skip to content

The Oncology Institute, Inc. TOI Business Sale Proceeds

Business Sale Proceeds at other companies

McKesson logo
McKessonMCK
$4M
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
$0
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$200M
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG

Other financials

Income statement

See full
Revenue$147.4M+41.2%
Operating income-$6.5M+34.3%
Net income-$2.5M+87.3%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$30.3M-23.8%
Total debt$104.9M+2.5%
Total equity-$16.3M-421%
Total assets$168.2M+2.6%

Cash flow

See full
Operating cash flow-$2.2M+55.6%
CapEx$1.0M+218%
Free cash flow-$3.3M+38.7%

Valuation

See full
Market cap$511.91M+133%
Enterprise value$586.58M+108%
P/S0.9×+0.4×

Profitability

See full
Operating margin-6%-2.1pp
Net margin-8%-2.7pp
FCF margin-5.1%

Returns & leverage

See full
Return on equity-277.6%-700pp
Debt / equity20.2×+17.3×
Current ratio1.5×-0.3×

Where this comes from

Reported directly by The Oncology Institute, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfProductiveAssets.

The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Oncology Institute, Inc.'s business sale proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Oncology Institute, Inc.'s business sale proceeds?
The Oncology Institute, Inc. (TOI) reported business sale proceeds of $0 in Q1 2026.
How has The Oncology Institute, Inc.'s business sale proceeds changed year-over-year?
The Oncology Institute, Inc.'s business sale proceeds decreased by 100.0% year-over-year, from $126K to $0.
What does business sale proceeds mean?
Cash received from divesting business units or subsidiaries, net of cash in the disposed entity.